Exercise for Cancer

(PAC ICare Trial)

PA
PA
Overseen ByPhysical Activity & Cancer Lab Research Manager
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Melanie Keats
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Building on previous research that shows the benefits of exercise, this study aims to find out how best to implement exercise in real-world settings. The study will assess the feasibility and acceptability of an embedding an automated referral tool and an exercise professional into standard cancer care impacts clinician referral and patient uptake of exercise programming. The study will assess how effective the exercise program is at improving patients' physical health, quality of life, symptom management, and overall wellbeing during different stages of their cancer journey (e.g., before treatment, on treatment, after treatment).

Who Is on the Research Team?

MK

Melanie Keats, PhD

Principal Investigator

Dalhousie University and Nova Scotia Health

Are You a Good Fit for This Trial?

This trial is for people diagnosed with cancer at any stage—before, during, or after treatment—who are able to participate in an exercise program. There are no detailed exclusions listed.

Inclusion Criteria

I am currently receiving cancer care or have had treatment in the past six months.
I have been diagnosed with cancer.
I am older than 19 years.
See 3 more

Exclusion Criteria

I do not have any severe conditions that prevent me from consenting or participating safely.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-treatment (Prehabilitation)

Participants preparing for surgery engage in a prehabilitation intervention to optimize physical functioning prior to surgery.

3-12 weeks
2-3 supervised exercise sessions per week

Active Treatment

Participants receiving adjuvant therapy or post-surgery engage in a 12-week exercise intervention.

12 weeks
2 supervised exercise sessions per week

Post-Treatment (Rehabilitation/Early Survivorship)

Participants who have completed treatment engage in a progressively tapered exercise program.

20 weeks
3 sessions per week initially, tapering to 1 session per week

Follow-up

Participants are monitored for safety and effectiveness after treatment.

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Exercise

Trial Overview

The study tests whether adding automatic referrals and access to an exercise professional within standard cancer care helps more patients join and benefit from exercise programs. It looks at effects on physical health, symptoms, and quality of life.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Pre-treatment (Prehabilitation)Experimental Treatment1 Intervention
Group II: Post-Treatment (Rehabilitation/Early Survivorship)Experimental Treatment1 Intervention
Group III: Active TreatmentExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Melanie Keats

Lead Sponsor

Trials
1
Recruited
70+

Queen Elizabeth II Health Sciences Centre

Collaborator

Trials
26
Recruited
14,200+